Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants

This study has been terminated.
(difficulty in recruiting subjects)
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
University of Louisville
ClinicalTrials.gov Identifier:
NCT00265005
First received: December 12, 2005
Last updated: October 11, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)